Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80 to 85% of all cases of lung cancer. There are different stages of NSCLC, ranging from 0 to 4; ...

OnCARlytics is under clinical development by Imugene and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to GlobalData, Phase I drugs for Bile Duct Cancer (Cholangiocarcinoma ...

Even small fitness improvements benefit those with advanced cancer stages or specific cancers like lung and digestive cancers. "Overall, cancer patients with high muscle strength or CRF levels ...

The five-year relative survival rate of small cell lung cancer—the odds that a cancer patient will live another five years compared to a non-patient—ranges from 7% to 30% depending on the ...

Doctors in the UK are hoping to transform the lives of people with deadly bile duct cancer. A new study – which has shown promising early results – matches the patient’s tumour to one or ...

Bile duct cancer, also called cholangiocarcinoma, is a type of cancer that starts in the bile ducts, small tubes that connect the liver and gallbladder to the small bowel. They carry a fluid ...

According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years. Overall, though, the news ...

FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim. According to data from Cancer Research UK, up to 70 per cent of all these ...